Former operator turned investor focused on growth-stage technology and consumer startups, Brandon Silvia brings product and GTM experience to early growth investing. He has led cross-functional teams in product management, marketing and commercial strategy, and is active in deal sourcing, diligence and board engagement for portfolio companies. Known for scaling customer acquisition and monetization models, he advises founders on go-to-market playbooks and unit-economics optimization while allocating capital across SaaS and direct-to-consumer opportunities.
Former operator turned investor focused on growth-stage technology and consumer startups, Brandon Silvia brings product and GTM experience to early growth investing. He has led cross-functional teams in product management, marketing and commercial strategy, and is active in deal sourcing, diligence and board engagement for portfolio companies. Known for scaling customer acquisition and monetization models, he advises founders on go-to-market playbooks and unit-economics optimization while allocating capital across SaaS and direct-to-consumer opportunities.
Operator-led growth investor focused on early growth technology and consumer businesses, deploying capital where product‑market fit is evident and GTM levers can be scaled. Prefers SaaS and direct‑to‑consumer models with clear unit economics, emphasizing CAC payback, LTV expansion and monetization paths. Investment style is hands‑on: sourcing and diligence informed by product and marketing experience, active board engagement, and playbook-driven value creation. Capital allocation favors concentrated, conviction bets with staged follow‑ons and KPI‑based risk management.
Operator-led growth investor focused on early growth technology and consumer businesses, deploying capital where product‑market fit is evident and GTM levers can be scaled. Prefers SaaS and direct‑to‑consumer models with clear unit economics, emphasizing CAC payback, LTV expansion and monetization paths. Investment style is hands‑on: sourcing and diligence informed by product and marketing experience, active board engagement, and playbook-driven value creation. Capital allocation favors concentrated, conviction bets with staged follow‑ons and KPI‑based risk management.
| Trades 897 | Longs Won 683/897 76% | Profit Factor 31.74 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $313,515.89 |
| Average Win $99,401.5 | Best Trade (Aug 31) $5.61M | Sharpe Ratio -10.18 |
| Average Loss -$9,996.66 | Worst Trade (Mar 30) -$192,071.64 | Z-Score 13.49 (100%) |
| Commissions $0 | Avg. Trade Length 1y 10m 4w 1d | Expectancy $73,302.05 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 16,949 | 15,254 | 13,559 | 11,864 | 10,169 | 8,475 | 6,780 | 5,085 | 3,390 | 1,695 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 35,057 | $4.9M | $10.83M | - | $5.93M | 121.07% | -7.354% |
ABBV AbbVie Inc. | 2,895 | $469,212.99 | $726,471.3 | - | $257,258.31 | 54.83% | -2.513% |
ABT Abbott Laboratories | 4,621 | $507,786.52 | $488,439.7 | - | -$19,346.82 | -3.81% | +0.085% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 7,000 | $318,500 | $526,750 | - | $208,250 | 65.38% | -0.172% |
ALL Allstate Corporation | 1,015 | $210,176 | $268,041.19 | - | $57,865.19 | 27.53% | -0.49% |
AMGN Amgen Inc. | 1,280 | $359,182.03 | $493,004.8 | - | $133,822.77 | 37.26% | -0.64% |
AMZN Amazon.com Inc | 3,047 | $303,128.95 | $827,504.23 | - | $524,375.28 | 172.99% | +15.321% |
ANGL VanEck Fallen Angel High Yield Bond ETF | 123,400 | $3.42M | $3.57M | - | $150,812.89 | 4.41% | -0.035% |
AVEM Avantis Emerging Markets Equity ETF | 20,961 | $1.34M | $1.88M | - | $535,809.78 | 39.97% | +0.101% |
AVGO Broadcom Inc. | 4,734 | $275,843.84 | $1.84M | - | $1.57M | 568.08% | +0.371% |
AXP American Express Company | 1,207 | $229,551.09 | $405,853.75 | - | $176,302.66 | 76.8% | -0.376% |
BAC Bank of America Corporation | 16,317 | $540,639.7 | $1.01M | - | $470,198.45 | 86.97% | +0.356% |
BIV Vanguard Intermediate-Term Bond ETF (likely mapping for ticker 0V1L) | 27,720 | $2.09M | $2.09M | - | $6,981.03 | 0.33% | -0.198% |
BP BP p.l.c. Sponsored ADR | 16,670 | $582,711.51 | $753,817.4 | - | $171,105.89 | 29.36% | +2.261% |
BRK-B Berkshire Hathaway Inc. | 5,271 | $1.76M | $2.7M | - | $941,243.38 | 53.63% | +0.365% |
BX Blackstone Inc. | 3,919 | $341,580.61 | $500,652.25 | - | $159,071.64 | 46.57% | -0.25% |
CAT Caterpillar Inc. | 1,622 | $407,450.97 | $1.32M | - | $914,170.85 | 224.36% | +0.701% |
CBNA Chain Bridge Bancorp Inc. | 8,000 | $190,240 | $364,320 | - | $174,080 | 91.51% | -0.241% |
CCJ Cameco Corporation | 5,610 | $224,085.61 | $484,591.8 | - | $260,506.19 | 116.25% | -2.097% |
CGDV Capital Group Dividend Value ETF | 427,200 | $17.08M | $21.16M | - | $4.09M | 23.93% | +0.63% |